Previous findings have shown that PD-1-positive/TIM3-positive (double-positive) T cells in mouse models of AML represent highly exhausted T cells within the immune microenvironment and are associated with earlier relapse after ASCT in patients with AML [17]. The gene discussed is PDCD1; the disease is acute myeloid leukemia.